Indication
Hepatitis B vaccination
Hepatitis B vaccination is a preventive immunization indication designed to induce active immunity against infection by the hepatitis B virus, a bloodborne and sexually transmitted hepadnavirus that targets the hepatic system. Read more about Hepatitis B vaccination
18 drugs 5 manufacturers
Drugs that treat it
Common Hepatitis B vaccination therapies.
RECOMBIVAX HB (PF) (hepatitis B virus vaccine recombinant/PF)
RECOMBIVAX HB (PF) (hepatitis B virus vaccine recombinant/PF)
TWINRIX (PF) (hepatitis A virus and hepatitis B virus vaccine/PF)
ENGERIX-B PEDIATRIC (PF) (hepatitis B virus vaccine recombinant/PF)
HEPLISAV-B (PF) (hepatitis B vaccine recombinant/vaccine adjuvant CpG 1018/PF)
PREHEVBRIO (PF) (hepatitis B virus vaccine recombinant,isoform S,M,L/PF)
ENGERIX-B ADULT (hepatitis B virus vaccine recombinant/PF)
HEPLISAV-B (hepatitis B vaccine recombinant/vaccine adjuvant CpG 1018/PF)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonHepatitis B vaccination is a preventive immunization indication designed to induce active immunity against infection by the hepatitis B virus, a bloodborne and sexually transmitted hepadnavirus that targets the hepatic system.
Infection can present as an acute hepatitis characterized by jaundice, constitutional symptoms, and acute liver failure, or it can progress to chronic infection marked by persistent viral replication, progressive fibrosis, cirrhosis, and hepatocellular carcinoma.
The target population for this indication includes infants, previously unvaccinated children and adolescents, all adults aged 19 through 59 years, and older adults with clinical, occupational, or behavioral risk factors, as well as individuals seeking pre-exposure prophylaxis or post-exposure prophylaxis against the virus.
- cdc.gov
Hepatitis B vaccination is a preventive immunization indication designed to induce active immunity against infection by the hepatitis B virus, a bloodborne and sexually transmitted hepadnavirus that targets the hepatic system Infection can present as an acute hepatitis characterized by jaundice, constitutional symptoms, and acute liver failure, or it can progress to chronic infection marked by persistent viral replication, progressive fibrosis, cirrhosis, and hepatocellular carcinoma
- cdc.gov
Hepatitis B vaccination is a preventive immunization indication designed to induce active immunity against infection by the hepatitis B virus, a bloodborne and sexually transmitted hepadnavirus that targets the hepatic system
- nih.gov
Infection can present as an acute hepatitis characterized by jaundice, constitutional symptoms, and acute liver failure, or it can progress to chronic infection marked by persistent viral replication, progressive fibrosis, cirrhosis, and hepatocellular carcinoma The target population for this indication includes infants, previously unvaccinated children and adolescents, all adults aged 19 through 59 years, and older adults with clinical, occupational, or behavioral risk factors, as well as indiv...
- cdc.gov
The target population for this indication includes infants, previously unvaccinated children and adolescents, all adults aged 19 through 59 years, and older adults with clinical, occupational, or behavioral risk factors, as well as individuals seeking pre-exposure prophylaxis or post-exposure prophylaxis against the virus
Personalize your experience
Follow Hepatitis B vaccination and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.